Choose language
< Return to main menu
Choose language
Services & Solutions
Services & Solutions
News & Events
Career
Platform
Small Molecule CRDMO
Small Molecule CRDMO
Oligonucleotide and Peptide CRDMO
WuXi AppTec's Research Chemistry Services (RCS) is a global leading chemistry platform offering synthetic and medicinal chemistry solutions to pharmaceutical and biotech companies, as well as research institutes and non-profit foundations worldwide. As an integrated small molecule drug discovery platform, RCS provides both Full-time Equivalent (FTE) and Fee-for-Service (FFS) models, aimed at streamlining the drug discovery process, with emphasis on productivity, speed, flexibility, quality and reliability.
Around 9,000 dedicated chemists
Robust track record with 434,000 compounds delivered in 2024
900+ clients with >5 years' collaboration including: 240+ clients with >10 years' collaboration
Consistently high customer satisfaction (Net Promoter Score >90)
Staying at the forefront of chemistry, investing heavily in new technologies and methodologies to expand our toolbox to help expedite project progress
WuXi STA, a subsidiary of WuXi AppTec, is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry, with global operations.
As a premier Contract Development and Manufacturing Organization (CDMO), WuXi STA offers our worldwide partners efficient, flexible and high-quality solutions for integrated CMC (Chemical, Manufacturing, and Control) from preclinical to commercial.
Integrated CMC platform for both API and drug product
9 development and manufacturing sites worldwide with one quality and EHS standard approved by all major regulatory agencies
Supported 50+ first-time new drugs approved in the US, Europe, China and Japan since 2017, 105 country approvals for branded drugs
Industry leading teams: 3,600+ process chemists & analytical scientists for API platform; 1,500+ formulation scientists & analytical scientists for drug product platform